{"id":"W2018650005","doi":"10.1158/1078-0432.ccr-09-1192","title":"Tipifarnib Plus Tamoxifen in Tamoxifen-Resistant Metastatic Breast Cancer: A Negative Phase II and Screening of Potential Therapeutic Markers by Proteomic Analysis","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"Tamoxifen; Medicine; Internal medicine; Oncology; Metastatic breast cancer; Breast cancer; Cancer; Metastasis","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008562845,0.0003701497,0.001557197,0.001062106,0.0003085842,0.00008678342,0.00063625,0.0003214956,0.002942592],"category_scores_gemma":[0.001283454,0.0002855204,0.0004044749,0.003342012,0.002359057,0.0001809486,0.0005117346,0.003759794,0.00000812281],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004983314,"about_ca_system_score_gemma":0.002873621,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02149488,"about_ca_topic_score_gemma":0.006031793,"domain_scores_codex":[0.9921339,0.001541615,0.001516255,0.001230558,0.002264686,0.001312953],"domain_scores_gemma":[0.9954248,0.001383829,0.0003271085,0.0009338626,0.001043806,0.0008866093],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.06217347,0.004054722,0.1966997,0.00150259,0.006837187,0.0004758771,0.001763692,0.0002255492,0.2807784,0.00008419331,0.007112222,0.4382924],"study_design_scores_gemma":[0.08402399,0.01409989,0.7711992,0.002337096,0.004612201,0.00009970438,0.002386433,0.0824796,0.02615709,0.001460165,0.009181516,0.001963116],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9855586,0.002023397,0.0002395683,0.008292738,0.0001625298,0.00264439,0.0008551182,0.0000345299,0.0001891269],"genre_scores_gemma":[0.9940011,0.002392536,0.0008524216,0.0002280551,0.0003093489,0.001065996,0.00004030255,0.00008280804,0.001027435],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5744995,"threshold_uncertainty_score":0.9999597,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1474246640642809,"score_gpt":0.5366681232496262,"score_spread":0.3892434591853453,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}